Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

NAGE

+ Watchlist+ Portfolio

Niagen Bioscience, Inc.

Physical productsConsumer brandTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$1.87
52-Week Range
$1.79 – $7.11
Market Cap
$145.72M
P/E (TTM)
15.33
EPS (TTM)
0.12
Dividend Yield
0.00%
Advanced Metrics
Price/Book
1.75
PEG Ratio
—
Return on Equity
13.32%
Return on Assets
1.69%
Gross Margin
63.86%
Operating Margin
2.28%
Profit Margin
8.37%
Current Ratio
5.93
Debt/Equity
0.03
Total Debt
$2.08M
Free Cash Flow
$2.92M
Revenue Growth
-20.00%
Earnings Growth
—
Enterprise Value
$78.75M

Market Snapshot

About

Niagen Bioscience, Inc. is a biotechnology company focused on NAD+ precursor supplements and longevity research. The company develops and markets nicotinamide riboside-based products targeting cellular health and aging.